Expert Video - Is remission the same in younger or older patients with AML?
Acute myeloid leukemia (AML) expert Dr. Barry Skikne discusses the differences in AML remission in younger and older patients with AML. In elderly patients, the duration of remission may be shorter than younger patients, although this may not always be the case. Older patients may not be able to have the most intensive treatment commonly used in induction and consolidation due to age, other health conditions, or for other reasons, or they may have an aggressive type of AML or other conditions that keep them from receiving intensive chemotherapy.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.